Skip to main content
. 2017 Nov 6;35(12):1297–1310. doi: 10.1007/s40273-017-0587-0

Fig. 3.

Fig. 3

Cost-effectiveness acceptability curve, probabilistic sensitivity analysis comparing IDgenetix®-guided treatment with treatment as usual. ADx IDgenetix® pharmacogenomic test